军人粗大的内捧猛烈进出视频 ,无码内射中文字幕岛国片,亚洲精品乱码久久久久久久久久久久,欧美日韩国产精品自在自线
Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
BUSINESS
>
Commercialized Products
MEDIA
>
News in NKF
CONTACT
CH / EN
Home
>
MEDIA
>
News in NKF
>
【Explore the future of the pharmaceutical industry】 Kingfriend will meet you in CPHI Barcelona!
2023-10-17
【Explore the future of the pharmaceutical industry】 Kingfriend will meet you in CPHI Barcelona!
share
Return
Previous
Nothing at all
Next
Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection
Relevant recommendations
2025-05-26
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing
2025-05-22
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
2025-05-20
Paclitaxel For Injection (Albumin Bound) approved by US FDA
2025-05-19
King-Friend will meet you in CPHI Frankfurt!
2025-05-13
King-Friend will meet you in CPHI Shanghai!
ABOUT
BUSINESS
MEDIA
CONTACT
Stock price
11.070
-0.039999999999999
?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd
Su ICP Bei No. 13012010
Disclaimers
Privacy policy
Site map